150 related articles for article (PubMed ID: 22982756)
21. Laser-induced ocular hypertension in albino CD-1 mice.
Fu CT; Sretavan D
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):980-90. PubMed ID: 19815738
[TBL] [Abstract][Full Text] [Related]
22. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.
Zhu Y; Zhang L; Gidday JM
Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330
[TBL] [Abstract][Full Text] [Related]
23. Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage.
Chauhan BC; Pan J; Archibald ML; LeVatte TL; Kelly ME; Tremblay F
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2969-76. PubMed ID: 12202517
[TBL] [Abstract][Full Text] [Related]
24. Genomic loci modulating retinal ganglion cell death following elevated IOP in the mouse.
Struebing FL; King R; Li Y; Cooke Bailey JN; ; Wiggs JL; Geisert EE
Exp Eye Res; 2018 Apr; 169():61-67. PubMed ID: 29421330
[TBL] [Abstract][Full Text] [Related]
25. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma.
Krishnan A; Kocab AJ; Zacks DN; Marshak-Rothstein A; Gregory-Ksander M
J Neuroinflammation; 2019 Sep; 16(1):184. PubMed ID: 31570110
[TBL] [Abstract][Full Text] [Related]
26. A dietary combination of omega-3 and omega-6 polyunsaturated fatty acids is more efficient than single supplementations in the prevention of retinal damage induced by elevation of intraocular pressure in rats.
Schnebelen C; Pasquis B; Salinas-Navarro M; Joffre C; Creuzot-Garcher CP; Vidal-Sanz M; Bron AM; Bretillon L; Acar N
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1191-203. PubMed ID: 19437028
[TBL] [Abstract][Full Text] [Related]
27. Mutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice.
McDowell CM; Luan T; Zhang Z; Putliwala T; Wordinger RJ; Millar JC; John SW; Pang IH; Clark AF
Exp Eye Res; 2012 Jul; 100():65-72. PubMed ID: 22575566
[TBL] [Abstract][Full Text] [Related]
28. Telmisartan Reduces Axon Degeneration in Mice With Experimental Glaucoma.
Hazlewood RJ; Kuchtey J; Wu HJ; Kuchtey RW
Invest Ophthalmol Vis Sci; 2020 May; 61(5):51. PubMed ID: 32460313
[TBL] [Abstract][Full Text] [Related]
29. Expression and activation of mitogen-activated protein kinases in the optic nerve head in a rat model of ocular hypertension.
Mammone T; Chidlow G; Casson RJ; Wood JPM
Mol Cell Neurosci; 2018 Apr; 88():270-291. PubMed ID: 29408550
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of intraocular pressure elevation in a modified laser-induced glaucoma rat model.
Biermann J; van Oterendorp C; Stoykow C; Volz C; Jehle T; Boehringer D; Lagrèze WA
Exp Eye Res; 2012 Nov; 104():7-14. PubMed ID: 22981807
[TBL] [Abstract][Full Text] [Related]
31. Optic nerve damage in experimental mouse ocular hypertension.
Mabuchi F; Aihara M; Mackey MR; Lindsey JD; Weinreb RN
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4321-30. PubMed ID: 14507876
[TBL] [Abstract][Full Text] [Related]
32. The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells.
Gu L; Kwong JMK; Yadegari D; Yu F; Caprioli J; Piri N
Neurosci Lett; 2018 Mar; 670():89-93. PubMed ID: 29398521
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma.
Johnson TV; Bull ND; Hunt DP; Marina N; Tomarev SI; Martin KR
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2051-9. PubMed ID: 19933193
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.
Martin KR; Quigley HA; Zack DJ; Levkovitch-Verbin H; Kielczewski J; Valenta D; Baumrind L; Pease ME; Klein RL; Hauswirth WW
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4357-65. PubMed ID: 14507880
[TBL] [Abstract][Full Text] [Related]
36. Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse.
Chen H; Wei X; Cho KS; Chen G; Sappington R; Calkins DJ; Chen DF
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):36-44. PubMed ID: 20702815
[TBL] [Abstract][Full Text] [Related]
37. Chronic ocular hypertensive rat model using microbead injection: comparison of polyurethane, polymethylmethacrylate, silica and polystyene microbeads.
Rho S; Park I; Seong GJ; Lee N; Lee CK; Hong S; Kim CY
Curr Eye Res; 2014 Sep; 39(9):917-27. PubMed ID: 24588104
[TBL] [Abstract][Full Text] [Related]
38. Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma.
Martin KR; Quigley HA; Valenta D; Kielczewski J; Pease ME
Exp Eye Res; 2006 Aug; 83(2):255-62. PubMed ID: 16546168
[TBL] [Abstract][Full Text] [Related]
39. Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
Morrison JC; Nylander KB; Lauer AK; Cepurna WO; Johnson E
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):526-31. PubMed ID: 9501862
[TBL] [Abstract][Full Text] [Related]
40. Rat chronic glaucoma model induced by intracameral injection of microbeads suspended in sodium sulfate-sodium hyaluronate.
Matsumoto Y; Kanamori A; Nakamura M; Negi A
Jpn J Ophthalmol; 2014 May; 58(3):290-7. PubMed ID: 24610540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
